February 8, 2024 – 2 min read
PHILADELPHIA, PA, FEBRUARY 2024 – Performance Development Group (PDG), a leading sales performance consultancy for the life sciences sector, announces the release of its 2024 State of Coaching Report that reveals the priorities, disparities, and perceived gaps affecting life sciences sales performance.
In late 2023, PDG conducted an extensive study of nearly 350 sales leaders and sales representatives from over 200 companies to discover the quantity and quality of sales coaching in the challenging and dynamic life sciences sector. The research not only sheds light on the current state of sales coaching in the industry but also provides actionable insights for organizations seeking to enhance their coaching strategies.
Key findings include:
“Our study reveals some stark disparities in sales coaching, emphasizing the urgent need for realignment,” said David Manning, Founder and Managing Partner at PDG. “The insights also underscore coaching’s critical role in performance and retention, reinforcing PDG’s commitment to empowering life sciences sales teams’ performance for sustained success.”
Read the report summary article and download the full report.
COACHING The Pharma Mid-Year Review Should Be a Coaching Diagnostic. Here’s How. by Performance Development Group, Coaching Excellence Practice A pharma mid-year coaching diagnostic is a structured assessment that evaluates each sales rep against the demands of the next six months, not the past six. Unlike a standard performance review, which measures what already happened, […]
COACHING The Three Biases Distorting How Pharma Sales Leaders See Their Teams by Sean Frontz, in partnership with PDG Content Team Why do pharma sales leaders overrate their teams? Research shows 62% of performance rating variance comes from the rater’s own tendencies, not from the person being rated. The three most common biases in life sciences […]
COACHING The Misdiagnosis Costing Your Field Force by PDG Content Team in partnership with Sean Frontz Why does sales training fail to improve field force performance in pharma? Pharma commercial organizations consistently misdiagnose underperformance as a skill deficit, so they respond with more training. But the data tells a different story: roughly 90% of performance failures stem […]
